INS and diabetes mellitus: The next step was made in February 2010 during the Diabetes Surgery University of Malaga meeting when it was concluded that metabolic surgery procedures could be performed in all patients 18–65 years old with insulin-dependent, difficult-to-control T2DM, as well as in patients treated with oral hypoglycemic drugs who are considered to be transferred to insulin therapy [7, 8].